Patent · US Expired

Formulation

US6686346B2 · kind B2 · utility

44Cited by

3References

29Claims

0Family size

Assignee

ASTRA CO., LTD. · SE

Inventors

Hans Nilsson · Lund, SE
Gordon Santesson · Hörby, SE

Key dates

Filing date	Aug 20, 2001
Grant date	Feb 3, 2004
Priority date	—
Expiry date	Aug 20, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A new metered unit dose comprising 40 &mgr;g or less of budesonide is disclosed as well as a formulation thereof and the use thereof for the treatment of conditions in the nose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.